Which has the lower trailing P/E, ETON or INVA?

INVA has the lower trailing P/E: ETON trades at 143.23 and INVA at 5.09. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ETON or INVA?

Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus INVA at 3.94%.

Is ETON or INVA more profitable?

INVA runs the higher net margin — ETON at 12.02% versus INVA at 80.56%.

How have ETON and INVA total returns compared?

Over the past 5 years, ETON delivered 63.04% and INVA delivered 4.52% annualized total return. Past performance doesn't predict future results.

Eton Pharmaceuticals, Inc. (ETON) vs Innoviva, Inc. (INVA)

A side-by-side comparison of Eton Pharmaceuticals, Inc. and Innoviva, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETON

Eton Pharmaceuticals, Inc.

$1.51B

$55.09HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

INVA

Innoviva, Inc.

$1.54B

$20.87HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT

Total return — ETON vs INVA

growth of $100 · dividends reinvested · last 8y

ETON +789.9% (+31.4%/yr)INVA +27.9% (+3.1%/yr)ETON compounded faster over this window

Log scale — wide-divergence pair

ETON INVA

ETON vs INVA: by the numbers

•INVA is the larger company ($1.54B vs $1.51B market cap).
•INVA trades at the lower trailing earnings multiple (5.09 vs 143.23 P/E), one valuation lens rather than an overall verdict.
•INVA converts more revenue to profit (80.56% vs 12.02% net margin).
•ETON grew revenue faster over the past five years (47.98% vs 3.94% CAGR).

Metrics side by side

Valuation

Metric	ETON	INVA
P/E ratio	143.23	5.09
Forward P/E	50.65	8.62
PEG ratio	N/A	0.49
P/S ratio	14.29	3.47
P/B ratio	32.39	1.25
EV / EBITDA	72.47	4.91
FCF yield	0.98%	12.23%

Profitability

Metric	ETON	INVA
Gross margin	57.87%	73.09%
Operating margin	0.09%	36.66%
Net margin	12.02%	80.56%
ROE	27.24%	28.97%
ROIC	20.41%	8.36%

Growth (annualized)

Metric	ETON	INVA
Revenue CAGR (5Y)	47.98%	3.94%
EPS CAGR (5Y)	N/A	12.71%
FCF CAGR (5Y)	N/A	-10.54%
Total return CAGR (5Y)	63.04%	4.52%

Frequently asked

Which has the lower trailing P/E, ETON or INVA?: INVA has the lower trailing P/E: ETON trades at 143.23 and INVA at 5.09. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ETON or INVA?: Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus INVA at 3.94%.
Is ETON or INVA more profitable?: INVA runs the higher net margin — ETON at 12.02% versus INVA at 80.56%.
How have ETON and INVA total returns compared?: Over the past 5 years, ETON delivered 63.04% and INVA delivered 4.52% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ETON analysis Full INVA analysis Interactive comparison tool

Dig into the metrics

Eton Pharmaceuticals P/E ratio Innoviva P/E ratio Eton Pharmaceuticals ROE Innoviva ROE Eton Pharmaceuticals operating margin Innoviva operating margin Eton Pharmaceuticals revenue growth Innoviva revenue growth Eton Pharmaceuticals free cash flow Innoviva free cash flow

Eton Pharmaceuticals & Innoviva appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.